Peter Haddad1, Serdar Murat Dursun. Show Affiliations » 1. Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK.
Abstract
Entities: Disease
Mesh： See more » Acute DiseaseAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useBenzodiazepines/adverse effectsBenzodiazepines/therapeutic useClinical Trials, Phase I as TopicDose-Response Relationship, DrugDyskinesia, Drug-Induced/etiologyHumansOlanzapinePatient DropoutsPerphenazine/adverse effectsPerphenazine/therapeutic useRandomized Controlled Trials as TopicSchizophrenia/drug therapyTreatment Outcome
Substances： See more » Antipsychotic AgentsBenzodiazepinesPerphenazineOlanzapine
Year: 2006 PMID： 16574710 DOI： 10.1177/0269881106062765
Source DB: PubMed Journal: J Psychopharmacol ISSN： 0269-8811 Impact factor: 4.153